Results 21 to 30 of about 4,698,923 (395)

A regimen with caplacizumab, immunosuppression and plasma exchange prevents unfavorable outcomes in immune-mediated TTP.

Blood, 2020
The anti-von Willebrand factor nanobody caplacizumab was licensed for adults with immune-mediated thrombotic thrombocytopenic purpura (iTTP) based on prospective controlled trials. However, few data are available on post-marketing surveillance.
P. Coppo, M. Bubenheim, É. Azoulay, L. Galicier, Sandrine Malot, N. Bigé, P. Poullin, F. Provôt, Nihal Martis, C. Presne, O. Moranne, R. Benainous, A. Dossier, A. Séguin, M. Hié, A. Wynckel, Yahsou Delmas, J. Augusto, P. Pérez, V. Rieu, C. Barbet, F. Lhôte, M. Ulrich, A. Rumpler, S. de Witte, T. Krummel, A. Veyradier, Y. Benhamou   +27 more
semanticscholar   +1 more source

Plasma exchange in patients with acute and acute-on-chronic liver failure: A systematic review

World Journal of Gastroenterology, 2020
BACKGROUND Acute liver failure (ALF) and acute-on-chronic liver (ACLF) carry high short-term mortality rate, and may result from a wide variety of causes.
E. Tan, Min-Xian Wang, J. Pang, G. Lee
semanticscholar   +1 more source

A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study

Alzheimer's & Dementia, 2020
This phase 2b/3 trial examined the effects of plasma exchange (PE) in patients with mild‐to‐moderate Alzheimer's disease (AD).
M. Boada, O. Lopez, J. Olazarán, L. Núñez, Michael Pfeffer, María Paricio, Jesús Lorites, G. Piñol-Ripoll, J. Gámez, F. Anaya, D. Kiprov, J. Lima, C. Grifols, M. Torres, M. Costa, J. Bozzo, Z. Szczepiorkowski, S. Hendrix, A. Páez   +18 more
semanticscholar   +1 more source

Therapeutic Plasma Exchange Using Membrane Plasma Separation.

American Society of Nephrology. Clinical Journal, 2020
Therapeutic plasma exchange is a blood purification technique designed for the removal of large molecular weight toxins such as pathogenic antibodies and lipoproteins.
Sadiq Ahmed, A. Kaplan
semanticscholar   +1 more source

Efficacy of therapeutic plasma exchange in severe COVID‐19 patients

British Journal of Haematology, 2020
Coronavirus disease 2019 (COVID-19) could lead to a sharp increase in the levels of inflammatory cytokines. We report the efficacy of therapeutic plasma exchange in severe COVID-19 patients with acute respiratory distress syndrome.
Li Zhang, Hui Zhai, Shasha Ma, Jiasheng Chen, Yu Gao   +4 more
semanticscholar   +1 more source

Therapeutic plasma exchange for COVID‐19‐associated hyperviscosity

Transfusion, 2020
Recent data suggests an association between blood hyperviscosity and both propensity for thrombosis and disease severity in patients with COVID‐19. This raises the possibility that increased viscosity may contribute to endothelial damage and multiorgan ...
Alexander D. Truong, Sara C. Auld, Nicholas A. Barker, Sarah Friend, A. T. Wynn, J. Cobb, Roman M. Sniecinski, Christin-Lauren Tanksley, Derek M. Polly, M. Gaddh, Michael Connor, H. Nakahara, H. C. Sullivan, C. Kempton, J. Guarner, A. Duncan, Cassandra D. Josephson, J. Roback, Sean R Stowell, C. Maier   +19 more
semanticscholar   +1 more source

Perspective: Is therapeutic plasma exchange a viable option for treating Alzheimer's disease?

Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 2020
Therapeutic plasma exchange, consisting of removing blood plasma and exchanging it with donated blood products, has been proposed for treating Alzheimer's disease (AD) to remove senescent or toxic factors. In preclinical studies, administration of plasma
Bruno P. Imbimbo, Stefania Ippati, Ferdinando Ceravolo, Mark Watling   +3 more
doaj   +1 more source

Effect of temperature and plasma on the exchange of apolipoproteins and phospholipids between rat plasma very low and high density lipoproteins

Journal of Lipid Research, 1978
The effect of temperature and plasma on the exchange of apoprotein C and phospholipids between VLDL and HDL was studied using 125I-labeled and 32P-labeled VLDL.
S Eisenberg
doaj   +1 more source

The successful use of therapeutic plasma exchange for severe COVID-19 acute respiratory distress syndrome with multiple organ failure

SAGE Open Medical Case Reports, 2020
The COVID-19 pandemic has brought about an urgent need for effective treatment, while conserving vital resources such as intensive care unit beds and ventilators. Antivirals, convalescent plasma, and biologics have been used with mixed results.
Philip Keith, M. Day, Carol Choe, Linda A. Perkins, L. Moyer, E. Hays, Marshall French, Kristi Hewitt, Gretchen Gravel, Amanda Guffey, L. Scott   +10 more
semanticscholar   +1 more source

Plasma exchange in critically ill COVID-19 patients

Critical Care, 2020
Introduction: The spectrum of coronavirus disease 2019 (COVID-19) ranges from asymptomatic infection to respiratory failure and death of patients Severely affected patients may develop a cytokine storm-like clinical syndrome with multi-organ failure and ...
C. Morath, M. Weigand, M. Zeier, C. Speer, Shilpa Tiwari-Heckler, U. Merle   +5 more
semanticscholar   +1 more source